We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Warts and all

14 February 2017 By Dominic Elliott

The Swiss bank’s socking 2.3 bln Swiss franc fourth-quarter loss followed a charge to settle U.S. mortgage litigation. Equities trading and Asian investment banking were dismal. But private banking and balance-sheet resilience favour Credit Suisse’s stock over richer-priced UBS.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)